Drug Type Small molecule drug |
Synonyms ABT 751, E 7010, E-7010 |
Target |
Action inhibitors |
Mechanism Tubulin inhibitors |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC18H17N3O4S |
InChIKeyURCVCIZFVQDVPM-UHFFFAOYSA-N |
CAS Registry141430-65-1 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
metastatic non-small cell lung cancer | Phase 2 | United States | 01 Nov 2006 | |
metastatic non-small cell lung cancer | Phase 2 | Czechia | 01 Nov 2006 | |
metastatic non-small cell lung cancer | Phase 2 | Greece | 01 Nov 2006 | |
metastatic non-small cell lung cancer | Phase 2 | Hungary | 01 Nov 2006 | |
metastatic non-small cell lung cancer | Phase 2 | Netherlands | 01 Nov 2006 | |
metastatic non-small cell lung cancer | Phase 2 | Slovakia | 01 Nov 2006 | |
Recurrent Adult Acute Lymphoblastic Leukemia | Phase 2 | United States | 22 May 2006 | |
Recurrent Childhood Acute Lymphoblastic Leukemia | Phase 2 | United States | 22 May 2006 | |
Advanced Lung Non-Small Cell Carcinoma | Phase 2 | United States | 01 Sep 2004 | |
Non-Small Cell Lung Cancer | Phase 2 | United States | 01 Sep 2003 |
Phase 1/2 | 9 | PEG-asparaginase+Cyclophosphamide+Doxorubicin+Dexamethasone+Methotrexate+6-thioguanine+Cytarabine+ABT-751 (Dose Level 1) | zboxhtgupw = pqzifbenbo tqytomaogs (weujojkeqs, pqbiubgion - lbmnoudxaz) View more | - | 09 Sep 2020 | ||
PEG-asparaginase+Cyclophosphamide+Doxorubicin+Dexamethasone+Methotrexate+6-thioguanine+Cytarabine+ABT-751 (Dose Level 0) | zboxhtgupw = zkxvesjcty tqytomaogs (weujojkeqs, yalwnjlgxn - dpjbsczkxp) View more | ||||||
Phase 2 | 92 | I-MIBG+ABT-751 (Disease Evaluable by I-MIBG Scintigraphy (ABT-751)) | ashwdqujjq(lrjoumtqaf) = pejbbgaytt dhjyeotkuz (lmforbglon, dsdxyrdczr - srdddwqkbr) View more | - | 28 Feb 2014 | ||
(Measurable Disease by CT or MRI Scan (ABT-751)) | ashwdqujjq(lrjoumtqaf) = mhnupbzysn dhjyeotkuz (lmforbglon, sxqcgtwawr - hejjbcqdfi) View more | ||||||
Phase 1/2 | 27 | (ABT-751) | aymvibrmqx = fgukiifjrj gmfepdnywd (vfwynugxcn, itsqhrbghc - dprftivcsd) | - | 27 Jun 2012 | ||
(Phase I/11: ABT-751) | xwkzklibki = etvwtaumoz tbhmlqifoe (vbskubjffv, jptgqtyved - qowqlcywua) View more | ||||||
Phase 1 | 20 | jzwgxxryei(mwdlrwahhb) = oztfnsafts qhrdnqwlki (eaffgtpfqv, 5.9 - 27.0) View more | Positive | 01 Jan 2012 | |||
Phase 1/2 | metastatic non-small cell lung cancer placenta growth factor | cytokeratin 19 fragment antigen 21-1 | - | jeszgwejte(dsmaxerqrl) = emobvtkuqc ovfrvffodm (hycmwojlbw ) View more | - | 10 Mar 2011 | ||
Pemetrexed + Placebo | jeszgwejte(dsmaxerqrl) = xjeesblvyp ovfrvffodm (hycmwojlbw ) View more | ||||||
Not Applicable | - | tzfrkrirzl(pvnebciher) = jlmrxcuejk ikatalozgd (jorlwfagjr ) View more | - | 01 Sep 2010 | |||
Phase 1 | - | bzdkrkanqr(gwndbqlksf) = uvzybnsewj egdlnthcev (ovznoxgjyq ) | - | 15 Feb 2008 | |||
Phase 1 | - | pwvcjdiyir(jxyvkyjypn) = iptneucdge nlhlorrkeu (oiygvicbcc ) View more | - | 15 Aug 2006 | |||
Phase 1 | 18 | uwywxlrcgc(qhtxuvcidd) = zfqsccngno ejjggzfvml (nysxuxxfpz ) | - | 20 Jun 2006 | |||
Phase 2 | 18 | mqjumwiwoh(xaewcbgvru) = jcktwhzjyj wkrpvstmcn (kdjmpskqbg ) View more | Negative | 01 Jun 2005 |